Revenue
No reported data
IN8BIO, INC. (INAB)
Price—Loading quote
Net income
2020
2021
2022
2023
2024
2025
Free cash flow
No reported data
Total cash / debt
CashTotal debt
2019
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Research & development | $10.2M | $17.0M | $16.8M | $14.1M | $7.3M | $5.4M |
| Operating expenses | $19.9M | $30.7M | $30.3M | $28.5M | $14.7M | $8.6M |
| Operating income | −$19.4M | −$30.4M | −$30.0M | −$28.5M | −$14.7M | −$8.6M |
| Net income | −$19.4M | −$30.4M | −$30.0M | −$28.5M | −$14.7M | −$8.6M |
| Basic EPSper diluted share | -$4.44 | -$17.05 | -$1.00 | -$1.36 | -$1.47 | -$3.02 |
| Diluted EPSper diluted share | -$4.44 | -$17.05 | -$1.00 | -$1.36 | -$1.47 | -$3.02 |
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| May 2, 2025Form 4 | BIOS Fund II, LP +8TenPercentOwner | BuyPre-Funded Warrants · derivative · indirect | 1.15M | — | — | 2.43M |
| May 2, 2025Form 4 | BIOS Fund III NT, LP +9TenPercentOwner | BuyPre-Funded Warrants · derivative · indirect | 1.15M | — | — | 2.43M |
| Oct 4, 2024Form 4 | BP Directors, LP +9TenPercentOwner | BuySeries C Warrant · derivative · indirect | 709.0K | — | — | 709.0K |
| Oct 4, 2024Form 4 | BP Directors, LP +9TenPercentOwner | BuyPre-Funded Warrants · derivative · indirect | 709.0K | — | — | 1.28M |
| Oct 4, 2024Form 4 | BIOS Fund II QP, LP +8TenPercentOwner | BuySeries C Warrant · derivative · indirect | 709.0K | — | — | 709.0K |